Home » Topics » Musculoskeletal, BioWorld Science

Musculoskeletal, BioWorld Science
RSS

Zeneca presents peptides for modifying autoimmune responses as in RA

July 27, 1998

Alexion's C5 inhibitor enters clinic for second autoimmune disorder

July 24, 1998

Dipeptidyl peptidase IV inhibitors developed at Tanabe

July 24, 1998

Antiinflammatory/immunomodulating peptide available for licensing from BTG

July 24, 1998

Daiichi team discloses ICAM-1 production inhibitors for inflammatory disorders

July 23, 1998

Sankyo prepares inhibitors of TNF-alpha production

July 23, 1998

HMR arthritis Rx up for FDA committee review

July 21, 1998

Invitation to access the ongoing telesymposium on rheumatoid arthritis therapies

July 17, 1998

Synthesis of new COX-2 inhibitor described by Merck scientists

July 16, 1998

TSL-225, a dipeptide inhibitor of dipeptidyl peptidase IV

July 15, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 30, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...